JNJ · Healthcare · $625.1B
After-hours $259.40+0.29%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 19 Drug Manufacturers - General peers
Quarterly Revenue Growth
“매출 $253억으로 전 분기 $241억에서 반등했어요 — STELARA(바이오시밀러 경쟁으로 매출 -56%) 역풍에도 이를 제외하면 두 자릿수”
In the company's words · 2026 2분기 earnings call